MEDIFAST (MED)
(Delayed Data from NYSE)
$19.77 USD
-0.71 (-3.47%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $19.84 +0.07 (0.35%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Medifast (MED) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.25 | $25.00 | $17.50 | 3.76% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $21.25. The forecasts range from a low of $17.50 to a high of $25.00. The average price target represents an increase of 3.76% from the last closing price of $20.48.
Analyst Price Targets (2 )
Broker Rating
Medifast currently has an average brokerage recommendation (ABR) of 4.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 4.00 a month ago based on two recommendations.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MED.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 0 | 0 |
ABR | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/6/2024 | D.A. Davidson | Linda B Weiser | Hold | Strong Sell |
5/1/2024 | Stephens | Jim Salera | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 4.00 |
ABR (Last week) | 4.00 |
# of Recs in ABR | 2 |
Average Target Price | $21.25 |
LT Growth Rate | NA |
Industry | Food - Miscellaneous |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | 0.36 |